Mitacs Globalink Intern contributing to the development of a novel drug for cancer treatment
It is Luis Arvizu’s comprehensive prospective on scientific discovery that brings him to Queen’s University, where he is currently researching under Dr. Myron Szewczuk from the Department of Biomedical and Molecular Sciences. Luis comes from Mexico’s Tec de Monterrey where he is pursuing his undergraduate degree in Engineering and Biotechnology.
Luis’ Globalink research project has him examining the novel use of a drug that inhibits the production and spread of cancer cells to other parts of the body, while making chemotherapy-resistant cells more susceptible to treatment.
“Participating in cancer research is highly motivating. Many of us have been affected in some way by this disease, which helps me stay focused on giving my all to this research project. My time in Canada is proving to be an invaluable experience. I am making connections, friendships and learning more and more every day.”
Luis looks forward to a career as a researcher, specifically in life sciences, where he can contribute to the scientific community and improve the quality of life of others facing disease and illness.
Mitacs thanks the Government of Canada and the Government of Ontario for their support of the Globalink research internship in this story. Across Canada, the Globalink program also receives support from Alberta Innovates, the Government of British Columbia, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Prince Edward Island, the Government of Quebec, the Government of Saskatchewanand Research Manitoba.
Do you have a business challenge that could benefit from a research solution? If so, contact Mitacs today to discuss partnership opportunities: BD@mitacs.ca
Mitacs
Mitacs empowers Canadian innovation through effective partnerships that deliver solutions to our most pressing problems. By driving economic growth and productivity, we create meaningful change to improve quality of life for all Canadians.
